Growth factors and chemotherapeutic modulation of breast cancer cells

Journal of Pharmacy and Pharmacology

Volumn 55, Issue 8, 2003, Pages 1135-1141

  Ciftci, Kadriye ^a   Su, Jiangfeng ^a   Trovitch, Peter B ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; DNA FRAGMENT; DOXORUBICIN; ESTRADIOL; ESTROGEN RECEPTOR; RECOMBINANT GROWTH FACTOR; RECOMBINANT SOMATOMEDIN C; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DISRUPTION; CELL STRAIN MCF 7; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG CYTOTOXICITY; DRUG EXPOSURE; DRUG POTENTIATION; DRUG RESPONSE; FLOW CYTOMETRY; GROWTH REGULATION; HUMAN; HUMAN CELL; METASTASIS; MITOSIS INHIBITION; NICK END LABELING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; DOXORUBICIN; ESTRADIOL; FEMALE; G1 PHASE; G2 PHASE; GROWTH SUBSTANCES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; OSTEOBLASTS; RECEPTORS, ESTROGEN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0042526046     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/002235703322277177     Document Type: Article

References (23)

1. Beckman, M. W., Niedaracher, D., Schnurch, H. G. (1997) Multistep carcinogenesis of breast cancer and tumor heterogeneity. J. Mol. Med. 75: 429
2. Borellini, B., Oka, T. (1989) Growth control and differentiation in mammary epithelial cells. Environ. Health Perspect. 80: 85
3. Choki, I., Sourla, A., Reyes-Moreno, C., Koutsilieris, M. (1998) Osteoblast-derived growth factors enhance doxorubicin-cytostasis of MCF-7 human breast cancer cells. Anticancer Res. 18: 4213-4224
4. D'Andrea, A., Seidman, A. (1997) Docetaxel and paclitaxel in breast cancer therapy: Present status and future prospects. Semin. Oncol. 24: S13-27-S13-44
5. Daniel, C. W., Silberstein, G. B., Van Horn, K., Strickland, P., Robinson, S. (1989) TGF-beta-1 induced inhibition of mammary ductal growth: Development specificity and characterization. Dev. Biol. 135: 20
6. De Jong, P. J., Van Diest, P., Van Der Valk, J., Baak, J. P. A. (1998) Expression of growth factors, inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops. J. Pathol. 184: 44-52
7. Diel, I. J., Kaufman, M., Goerner, R., Costa, S. D., Kaul, S., Bastert, G. (1992) Detection of tumor cells in bone marrow of patients with primary breast cancer: A prognostic factor for distant metastases. J. Clin. Oncol. 10: 1534-1539
8. El-Tanani, D., Green, C. D. (1997) Interaction between estradiol and growth factors in the regulation of specific gene expression in MCF-7 human breast cancer cells. J. Steroid Biochem. Biol. 60: 269-276
9. Fornari, J. R., Jarvis, W. D., Grant, S., Orr, M. S., Randolph, J. K., White, F. K. H., Mumaw, V. R., Lovings, E. T., Freeman, R. H., Gewirt, D. H. (1994) Induction of differentiation and growth arrested associated with nascent (nonoligosomal) DNA fragmentation and reduced c-myc expression in MCF-7 human breast tumor cells after continuous exposure to sublethal concentration of doxorubicin. Cell Growth Differ. 5: 723-733
10. Gavrieli, Y., Sherman, Y., Ben-Sasson, S. A. (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119: 493
11. Hermann, H. M., Lorenz, R., Voll, M., Grunke, W., Woith, W., Kalden, J. R. (1994) A rapid and simple method for the isolation of apoptotic DNA fragments. Nucl. Acid. Res. 22: 5506-5507
12. Koutsilieris, M., Reyes-Moreno, C., Choki, I., Sourla, A., Doillon, C., Pavlidis, N. (1999) Chemotherapy toxicity of human MCF-7 and MDA-MB 231 breast cancer cells is altered by osteoblast derived growth factors. Mol. Med. 5: 86-97
13. Kyprianou, N., Kononen, J., Helin, K. (1991) Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res. 51: 62
14. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: An application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63
15. Myers, C. (1997) Anthracyclines and DNA intercalators. In: Holland, J. F., Frei, E., Bast, R. C. Jr. (eds) Cancer Medicine. 4th edn, Williams & Wilkins, Philadelphia, pp. 977-988
16. Nass, S. J., Dickson, R. B., Amundadottir, L. T. (1996) Role for BCL-xL in the regulation of apoptosis by EGF and TGFbeta1 in c-MYC overexpressing mammary epithelial cells. Biochem. Biophys. Res. Commun. 227: 248
17. Oh, Y., Müller, H. L., Rosenfeld, R. G. (1995) Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J. Biol. Chem. 270:13589-13592
18. Parrizas, G., Leroith, D. (1997) Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of bcl-xL gene product. Endocrinology 138: 7213-7227
19. Rasmussen, A. A., Cullen, K. J. (1998) Paracrine/autocrine regulation of breast cancer by the insulin-like growth factors. Breast Cancer Res. Treat. 47: 219
20. Resincoff, J. L., Burgaud, H. L., Rotman, D., Abraham, D., Baserga, R. (1995) Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptor. Cancer Res. 55: 3739-3741
21. Surmacz, E., Guvakova, M. A., Nolan, M. K (1998) Type I insulin-like growth factor receptor function in breast cancer. Breast Cancer Res. Treat. 47: 255
22. Texixeira, J. C., Reed, M., Pratt, M. A. C. (1995) Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cell. Cancer Res. 55: 3902-3907
23. Valverius, E. M., Walker-Jones, D., Bates, S. E., Stamfer, M. R., Clark, R., McCormick, F., Dickson, R. B., Lippman, E. (1989) Production and responsiveness to transforming growth factor beta in normal and oncogenes transformed human mammary epithelial cells. Cancer Res. 49: 6269-6273